Board of Directors
Daotian Fu
Chair of ChAbS Board of Directors,
Management,
ImmuLogic Ltd
Mitchell Ho
Editor-in-Chief, Antibody Therapeutics;
Chair, ChAbS Advisory Board;
ChAbS Founding Board Member
Senior Investigator and Deputy Chief
of the Laboratory of Molecular Biology
& Director of the Antibody Engineering Program at NCI, NIH
Fubao Wang
ChAbS Founding Board Member
Chief Regulatory Officer & Chief Technical Officer
Medera/ Sardocor
Jingsong Wang
ChAbS Board Member
Founder, Board Chair & CEO,
Harbour BioMed;
Chairman,
Nona Biosciences
Shouye Wang
Founder, Inaugural President of ChAbS
Senior Director,
WuXi XDC
Advisory Board
Mitchell Ho (Chair)
National Cancer Institute, NIH
Chuan-Chu Chou
Free-lance Consultant
Ningning Ma
Shenyang Pharmaceutical University
Lianshan Zhang
Jiangsu Hengrui Medicine
Zhiqiang An
U. of Texas Health Science Center
Yang-Xin Fu
Tsinghua University
David Shen
Propeller Bio
Yanfeng Zhang
AlaMab Therapeutic
Chris Chen
Wuxi Biologics
Audrey Jia
DataRevive LLC
Lin Sun-Hoffman
Liu, Zheng, Chen & Hoffman LLP
Zhenping Zhu
Helixon
Yan Chen
Elpis Biopharmaceutics
Bo Liu
Umabs Therapeutics
Zhidan Tu
Zipcode Bio
Kerry A. Chester
University College London
Shan Lu
U of Massachusetts Medical School
Chengbin Wu
EpimAb Biotherapeutics
Executive Committee
Yufang Shao
President
Ning Zhang
Stone Shi
Cong Yao
General Manager
Hongwei Han
Peng Lin
Guangbo Liu
Zheng Xiao
You Li
Wei Jia
Hong Pan
Global Volunteers
 |  |  |
|---|---|---|
 |  |  |
 |  |  |
 |  |  |
 |  |  |
